Increasing Use of Oscillometry for Lung Testing
A national survey shows that while most laboratories use oscillometry technology, lack of standardized guidelines and high costs limit its growth.
A national survey shows that while most laboratories use oscillometry technology, lack of standardized guidelines and high costs limit its growth.
A national survey shows that while most laboratories use oscillometry technology, lack of standardized guidelines and high costs limit its growth.
Read MoreThe strategic partnership will launch the Thorasys tremoflo C2 oscillometer in the United States.
Read MoreChanges in lung function are of critical importance to patients with cystic fibrosis (CF), as lung function is a key indicator of disease progression and treatment effectiveness.
Read MoreWatch RT Magazine’s on-demand webinar on asthma care and learn more about how spirometry, FeNO, and oscillometry are used in diagnosis and disease management.
Read MoreVitalograph is expanding its Clinical Trial services portfolio with centralized DLCO, decentralized spirometry, and integrated oscillometry solutions.
Read MoreA closer look as some of the latest spirometers and pulmonary function testing (PFT) diagnostic devices on the market from coVita, FutureMed, MGC Diagnostics, and Vitalograph.
Read MoreDeveloped in partnership with Thorasys, the Vitalograph tremoflo C-100 Oscillometer helps to detect the presence of small airway impairment, providing additional information to standard PFTs.
Read More